Loading...
•
Mar 31, 2020
Ashland Q2 2020 Earnings Report
Ashland's financial results for the second quarter of fiscal 2020 were reported, showing a decrease in sales but consistent adjusted income compared to the prior-year quarter.
Key Takeaways
Ashland reported a 9% decrease in sales to $610 million compared to the prior-year quarter. The net loss was $582 million, primarily due to a non-cash goodwill impairment charge. Adjusted income from continuing operations was $52 million, consistent with the prior-year quarter, and adjusted EBITDA was $142 million, also consistent with the prior year.
Sales were $610 million, a 9% decrease compared to the prior-year quarter.
Net loss amounted to $582 million, driven mainly by a goodwill impairment charge.
Adjusted income from continuing operations was $52 million, consistent with the prior-year quarter.
Adjusted EBITDA was $142 million, consistent with the prior-year quarter, as lower sales were offset by reduced operating expenses.
Ashland
Ashland
Ashland Revenue by Segment
Revenue by Segment
Life Sciences Revenue
CapyFin.comPersonal Care Revenue
CapyFin.comSpecialty Additives Revenue
CapyFin.comIntermediates Revenue
CapyFin.com Forward Guidance
Chairman and CEO Guillermo Novo will provide commentary on the outlook for Ashland during the conference call with securities analysts on Wednesday, May 6, 2020.
Revenue & Expenses
Visualization of income flow from segment revenue to net income